Target Trial Emulation and Bias Through Missing Eligibility Data: An Application to a Study of Palivizumab for the Prevention of Hospitalization Due to Infant Respiratory Illness. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/aje/kwac202
PubMed Identifier: 36509514
Publication URI: http://europepmc.org/abstract/MED/36509514
Type: Journal Article/Review
Volume: 192
Parent Publication: American journal of epidemiology
Issue: 4
ISSN: 0002-9262